Table 3.
Concentration | Control | FGR | P values |
---|---|---|---|
Maternal peripheral blood | |||
1st T | n = 12 | n = 12 | |
ADMA (μmol/L) | 1.684 ± 0.236 | 2.709 ± 0.272 | < 0.001*** |
NO (μmol/L) | 24.74 ± 8.69 | 17.72 ± 6.30 | 0.034* |
VEGF (pg/mL) | 935.97 ± 117.87 | 994.26 ± 108.00 | 0.220 |
PLGF (pg/mL) | 305.27 ± 29.69 | 276.60 ± 49.87 | 0.101 |
2nd T | n = 12 | n = 12 | |
ADMA (μmol/L) | 2.122 ± 0.269 | 2.742 ± 0.404 | < 0.001*** |
NO (μmol/L) | 20.27 ± 5.55 | 16.16 ± 5.44 | 0.080 |
VEGF (pg/mL) | 1082.36 ± 187.74 | 1115.43 ± 190.92 | 0.673 |
PLGF (pg/mL) | 303.54 ± 41.03 | 290.38 ± 71.27 | 0.583 |
3rd T | n = 12 | n = 12 | |
ADMA (μmol/L) | 2.620 ± 0.428 | 2.358 ± 0.340 | 0.111 |
NO (μmol/L) | 18.63 ± 4.46 | 15.12 ± 2.83 | 0.031* |
VEGF (pg/mL) | 1115.17 ± 209.96 | 911.53 ± 162.24 | 0.014* |
PLGF (pg/mL) | 311.18 ± 45.06 | 239.47 ± 38.90 | < 0.001*** |
After delivery | n = 12 | n = 12 | |
ADMA (μmol/L) | 2.489 ± 0.230 | 2.454 ± 0.456 | 0.817 |
NO (μmol/L) | 16.97 ± 2.40 | 15.62 ± 1.21 | 0.096 |
VEGF (pg/mL) | 1017.60 ± 143.87 | 984.49 ± 156.06 | 0.594 |
PLGF (pg/mL) | 270.57 ± 68.68 | 273.15 ± 49.25 | 0.917 |
Cord blood | n = 20 | n = 20 | |
ADMA (μmol/L) | 2.448 ± 0.422 | 2.978 ± 1.028 | 0.039* |
NO (μmol/L) | 19.65 ± 6.30 | 15.70 ± 6.21 | 0.053 |
VEGF (pg/mL) | 1051.15 ± 146.61 | 1038.93 ± 148.25 | 0.795 |
PLGF (pg/mL) | 288.46 ± 57.18 | 254.52 ± 53.60 | 0.041* |
Placental tissue | n = 16 | n = 16 | |
ADMA (μmol/g) | 3.491 ± 0.678 | 4.108 ± 0.933 | 0.041* |
NO (μmol/g) | 30.79 ± 7.45 | 25.41 ± 6.89 | 0.025* |
Values are expressed as mean ± SD
FGR fetal growth restriction, ADMA asymmetric dimethylarginine, NO nitric oxide, VEGF vascular endothelial growth factor, PLGF placental growth factor, T trimester
*P < 0.05, ***P < 0.001